OVERVIEW

Treating Myeloproliferative Neoplasms: Spotlight on Myelofibrosis is organized by The Leukemia & Lymphoma Society (LLS).

Recorded on: May 15, 2024  
Date of initial release: July 15, 2024
Valid for CME/CE credit through: January 15, 2026

Learning Objectives:
At the conclusion of this activity, participants will be able to:

  • Provide an overview of MPNs
  • Apply diagnostic criteria for a correct diagnosis and grade
  • Explain low-risk symptomatic myelofibrosis, intermediate, and high-risk primary or secondary, including genetic mutations, and risk stratification
  • Apply data on approved treatments and clinical trials into clinical practice
  • Implement strategies across the care team to educate and support patients
Credits

Joint Accreditation Statement:
Physician Continuing Medical Education
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and The Leukemia & Lymphoma Society.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Postgraduate Institute for Medicine designates this CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Registered Nursing Credit Designation
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.

Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.

Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Social Worker Continuing Education
The Leukemia & Lymphoma Society (LLS) Provider Number 1105, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: 12/10/2023-12/10/2026. Social workers completing this course receive 1.0 clinical continuing education credit.

The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Departments State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0117. LLS maintains responsibility for the program. Social workers will receive 1.0 clinical CE contact hour for this activity.

  • 1 AMA PRA Category 1 Credit™
  • 1 Contact Hours
  • 1 IPCE
  • 1 CE Credits
  • 1 C.E. contact hours
  • TARGET AUDIENCE

    PhysicianNursingPhysician AssistantSocial WorkerOncologistsNursesHematologistOther Health Professionals

    SPECIALITIES

    HematologyOncology

    RELATED ONLINE COURSES

    May 25, 2022 - Nov 30, 2026 | Webcast

    State required course for Connecticut ...
    5 AMA PRA Category 1 Credits™
    ...
    More actions
    US$180

    Aug 23, 2022 - Nov 30, 2026 | Webcast

    State required course for New Jersey
    3 AMA PRA Category 1 Credits™
    ...
    More actions
    US$15.20